Loading…
A graduate medical school in Singapore, a Duke and NUS partnership training clinician-scientists and running biomedical and clinical research.
Atom Bioworks / University of Pennsylvania / GenScript / Duke-NUS Medical School
Released May 31, 2026
Masked discrete-diffusion model over millions of full-length mRNAs, steered by Monte Carlo tree search for joint codon optimization and UTR design.
Peptide developability predictor scoring solubility, permeability, toxicity, and binding from amino-acid sequences or chemically modified SMILES.
Duke-NUS Medical School / Genome Institute of Singapore / National University of Singapore / National Cancer Centre Singapore / Yale University
Released September 19, 2025
Single-cell foundation model domain-adapting Llama-3.1-8B on 1.3M gastric cancer cells with gene-family cell sentences instead of ranked-gene order.
University of Pennsylvania / Duke University / Duke-NUS Medical School
Released July 10, 2025
De novo design of heavy metal-binding peptides by classifier-guided diffusion over ESM-2 embeddings, with Cu and Zn binders validated in vitro.
Agency for Science, Technology and Research (A*STAR) / Singapore National Eye Centre / Duke-NUS Medical School / SingHealth / Singapore General Hospital / National Cancer Centre Singapore / National University of Singapore / Tsinghua University / Harvard Medical School / Stanford University / University of Birmingham / University of Nottingham / University of Calgary
Released June 30, 2025
Self-supervised medical imaging foundation model pretrained on 3.3 million CT, X-ray, ultrasound, pathology, OCT, fundus, and dermoscopy images.